Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
- PMID: 29688155
- DOI: 10.1148/radiol.2018171768
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
Abstract
Purpose To report long-term outcomes of radiation segmentectomy (RS) for early hepatocellular carcinoma (HCC). The authors hypothesized that outcomes are comparable to curative treatments for patients with solitary HCC less than or equal to 5 cm and preserved liver function. Materials and Methods This retrospective study included 70 patients (median age, 71 years; range, 22-96 years) with solitary HCC less than or equal to 5 cm not amenable to percutaneous ablation who underwent RS (dose of >190 Gy) between 2003 and 2016. Patients who underwent subsequent curative liver transplantation were excluded to eliminate this confounding variable affecting survival. Radiologic response of time to progression and median overall survival were estimated by using the Kaplan-Meier method per the guidelines of the European Association for the Study of the Liver (EASL) and the World Health Organization (WHO). Results Seventy patients were treated with RS over 14 years. Sixty-three patients (90%) showed response by using EASL criteria, of which 41 (59%) showed complete response. Fifty patients (71%) achieved response by using WHO criteria, of which 11 (16%) achieved complete response. Response rates at 6 months were 86% and 49% by using EASL and WHO criteria, respectively. Median time to progression was 2.4 years (95% confidence interval: 2.1, 5.7), with 72% of patients having no target lesion progression at 5 years. Median overall survival was 6.7 years (95% confidence interval: 3.1, 6.7); survival probability at 1, 3, and 5 years was 98%, 66%, and 57%, respectively. Overall survival probability at 1, 3, and 5 years was 100%, 82%, and 75%, respectively, in patients with baseline tumor size less than or equal to 3 cm (n = 45) and was significantly longer than in patients with tumors greater than 3 cm (P = .026). Conclusion RS provides response rates, tumor control, and survival outcomes comparable to curative-intent treatments for selected patients with early-stage HCC who have preserved liver function. © RSNA, 2018 Online supplemental material is available for this article.
Comment in
-
Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?Radiology. 2018 Jun;287(3):1059-1060. doi: 10.1148/radiol.2018180163. Epub 2018 Apr 24. Radiology. 2018. PMID: 29688156 No abstract available.
Similar articles
-
Efficacy and Safety of Radiation Segmentectomy with 90Y Resin Microspheres for Hepatocellular Carcinoma.Radiology. 2024 May;311(2):e231386. doi: 10.1148/radiol.231386. Radiology. 2024. PMID: 38713023
-
Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.AJR Am J Roentgenol. 2019 Dec;213(6):1232-1239. doi: 10.2214/AJR.18.20842. Epub 2019 Oct 15. AJR Am J Roentgenol. 2019. PMID: 31613663
-
Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.Abdom Radiol (NY). 2018 Jul;43(7):1723-1738. doi: 10.1007/s00261-017-1391-1. Abdom Radiol (NY). 2018. PMID: 29147766 Review.
-
Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.Radiology. 2017 Jun;283(3):895-905. doi: 10.1148/radiol.2016160718. Epub 2016 Dec 7. Radiology. 2017. PMID: 27930089
-
Challenge and hope in radiotherapy of hepatocellular carcinoma.Yonsei Med J. 2009 Oct 31;50(5):601-12. doi: 10.3349/ymj.2009.50.5.601. Epub 2009 Oct 20. Yonsei Med J. 2009. PMID: 19881961 Free PMC article. Review.
Cited by
-
Selective internal radiation therapy segmentectomy: A new minimally invasive curative option for primary liver malignancies?World J Gastroenterol. 2024 May 14;30(18):2379-2386. doi: 10.3748/wjg.v30.i18.2379. World J Gastroenterol. 2024. PMID: 38764771 Free PMC article. Review.
-
Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications.Cancers (Basel). 2024 Mar 25;16(7):1271. doi: 10.3390/cancers16071271. Cancers (Basel). 2024. PMID: 38610949 Free PMC article. Review.
-
Revisiting the Institut Mutualiste Montsouris Difficulty Classification of Laparoscopic Liver Resection with the Data from a Personal Series-Evaluations for the Difficulty of Left Medial Sectionectomy and Length of Hospital Stay.J Pers Med. 2024 Feb 22;14(3):232. doi: 10.3390/jpm14030232. J Pers Med. 2024. PMID: 38540975 Free PMC article.
-
Radiation Segmentectomy for Hepatocellular Carcinoma.Curr Oncol. 2024 Jan 23;31(2):617-628. doi: 10.3390/curroncol31020045. Curr Oncol. 2024. PMID: 38392039 Free PMC article. Review.
-
Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma: A Practical Review of Evidence.Cancers (Basel). 2024 Feb 4;16(3):669. doi: 10.3390/cancers16030669. Cancers (Basel). 2024. PMID: 38339418 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical